journal article·2022-09-14

Novel Cocktail Therapy Based on a Nanocarrier with an Efficient Transcytosis Property Reverses the Dynamically Deteriorating Tumor Microenvironment for Enhanced Immunotherapy

Jiayan Wu, Zhaopei Guo, Weidong Ni, Yuanji Feng, Xiaoya Guo, Meng Meng, Yunan Yuan, Lin Lin, Jie Chen, Huayu Tian, Xuesi Chen

Nano Letters· Volume 22· Issue 17
Publisher page

Abstract

The immune checkpoint blockade (ICB) faces a low response rate in clinical cancer treatment. Chemotherapy could enhance the response rate of the ICB, but patients would suffer from side effects. The off-target toxicity could be reduced by loading the chemotherapeutic agent through nanocarriers. Therefore, we developed a polymeric carrier for doxorubicin (DOX) loading to form DOX nanoparticles (DOX NPs), which were spatiotemporally responsive to the tumor microenvironment (TME). DOX NPs had an efficient transcytosis property for deep tumor infiltration and sustained drug release ability. Unfortunately, a binary therapy of DOX NPs and ICB induces tumor adaptive resistance and causes dynamic deterioration of the TME. We propose for the first time that TGF-β1 is a major cause of tumor adaptive resistance and developed an immune cocktail therapy containing DOX NPs, ICB, and TGF-β1 gene silencing nanoparticles. This therapy successfully overcame tumor adaptive resistance by reversing the immunosuppressive TME and achieved enhanced tumor treatment efficiency.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Cancer Immunotherapy and Biomarkers · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, People’s Republic of China

University of Science and Technology of China, Hefei 230026, People’s Republic of China

College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, People’s Republic of China

Funding

Ministry of Science and Technology of the People's Republic of China · National Natural Science Foundation of China

References (40)

Show source-provided references
1. 10.1016/j.immuni.2020.10.02010.1016/j.immuni.2020.10.020 ↗
2. 10.1038/s41573-019-0052-110.1038/s41573-019-0052-1 ↗
3. 10.1002/adma.20170711210.1002/adma.201707112 ↗
4. 10.1093/nsr/nwab15910.1093/nsr/nwab159 ↗
5. 10.1007/s11864-017-0492-y10.1007/s11864-017-0492-y ↗
6. 10.31635/ccschem.020.20200014010.31635/ccschem.020.202000140 ↗
7. 10.1038/nature2134910.1038/nature21349 ↗
8. 10.1016/j.ccell.2020.09.00110.1016/j.ccell.2020.09.001 ↗
9. 10.1016/j.bioactmat.2021.05.03610.1016/j.bioactmat.2021.05.036 ↗
10. 10.1038/s41591-019-0432-410.1038/s41591-019-0432-4 ↗
11. 10.1126/sciadv.abc782810.1126/sciadv.abc7828 ↗
12. 10.1021/acs.nanolett.1c0278210.1021/acs.nanolett.1c02782 ↗
13. 10.1002/adma.20180588810.1002/adma.201805888 ↗
14. 10.1038/nri.2016.10710.1038/nri.2016.107 ↗
15. 10.1016/j.nantod.2021.10122510.1016/j.nantod.2021.101225 ↗
16. 10.1016/j.pcad.2006.10.00210.1016/j.pcad.2006.10.002 ↗
17. 10.26599/NTM.2022.913000110.26599/NTM.2022.9130001 ↗
18. 10.1016/j.addr.2020.07.02010.1016/j.addr.2020.07.020 ↗
19. 10.1021/jacs.7b1277610.1021/jacs.7b12776 ↗
20. 10.1016/S0040-4020(02)00489-110.1016/S0040-4020(02)00489-1 ↗
21. 10.1016/j.immuni.2019.11.00710.1016/j.immuni.2019.11.007 ↗
22. 10.1016/j.nantod.2021.10119410.1016/j.nantod.2021.101194 ↗
23. 10.1038/s41590-019-0433-y10.1038/s41590-019-0433-y ↗
24. 10.3390/cells902027310.3390/cells9020273 ↗
25. 10.1021/acs.nanolett.8b0429610.1021/acs.nanolett.8b04296 ↗
26. 10.1038/s41565-019-0485-z10.1038/s41565-019-0485-z ↗
27. 10.1021/jacs.1c0974110.1021/jacs.1c09741 ↗
28. 10.1172/JCI9228410.1172/JCI92284 ↗
29. 10.1073/pnas.181218611610.1073/pnas.1812186116 ↗
30. 10.1038/s41467-021-22875-w10.1038/s41467-021-22875-w ↗
31. 10.1016/j.cell.2019.10.02910.1016/j.cell.2019.10.029 ↗
32. 10.1016/j.immuni.2011.02.02110.1016/j.immuni.2011.02.021 ↗
33. 10.1038/s41586-020-2836-110.1038/s41586-020-2836-1 ↗
34. 10.1016/j.immuni.2018.03.03710.1016/j.immuni.2018.03.037 ↗
35. 10.1186/s12943-021-01489-210.1186/s12943-021-01489-2 ↗
36. 10.1158/1078-0432.CCR-17-311210.1158/1078-0432.CCR-17-3112 ↗
37. 10.1126/scitranslmed.aay845610.1126/scitranslmed.aay8456 ↗
38. 10.1038/s41467-021-27078-x10.1038/s41467-021-27078-x ↗
39. 10.1038/s41467-020-15404-810.1038/s41467-020-15404-8 ↗
40. 10.1158/2159-8290.CD-14-086310.1158/2159-8290.CD-14-0863 ↗